[
    [
        {
            "time": "2021-08",
            "original_text": "华东医药：全球独家胶原蛋白刺激剂8月正式登陆中国大陆市场",
            "features": {
                "keywords": [
                    "华东医药",
                    "胶原蛋白刺激剂",
                    "独家",
                    "中国市场"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：全球独家胶原蛋白刺激剂8月正式登陆中国大陆市场",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-10",
            "original_text": "华东医药：将于8月10日发布2021年半年度报告",
            "features": {
                "keywords": [
                    "华东医药",
                    "半年度报告",
                    "发布"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华东医药：将于8月10日发布2021年半年度报告",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-08",
            "original_text": "华东医药：少女针已开展医美医生专业培训，上市后首发医院100家",
            "features": {
                "keywords": [
                    "华东医药",
                    "少女针",
                    "医美医生",
                    "培训",
                    "首发医院"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：少女针已开展医美医生专业培训，上市后首发医院100家",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022",
            "original_text": "华东医药：西格列汀化合物在我国的专利将于2022年到期",
            "features": {
                "keywords": [
                    "华东医药",
                    "西格列汀",
                    "专利",
                    "到期"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华东医药：西格列汀化合物在我国的专利将于2022年到期",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021",
            "original_text": "医药生物行业：十四五开启血制品新成长周期，重点推荐天坛生物、博雅生物等",
            "features": {
                "keywords": [
                    "医药生物",
                    "十四五",
                    "血制品",
                    "天坛生物",
                    "博雅生物"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业：十四五开启血制品新成长周期，重点推荐天坛生物、博雅生物等",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]